NCT06671548 2026-02-02Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine FibroidsQilu Pharmaceutical Co., Ltd.Phase 3 Recruiting120 enrolled
NCT07378098 2026-01-30to Evaluate the Efficacy and Safety of KLH-2109 in Patients With Uterine Fibroids and MenorrhagiaJW PharmaceuticalPhase 3 Recruiting254 enrolled